About us

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

About us

Epigenomcs AG acts as a holding company and is dedicated to managing its own assets, acquiring, holding and disposing of investments in companies in Germany and abroad, particularly in the field of minimally invasive blood tests for cancer detection, as well as investing in other assets.

Founded 1998
IPO 19th July 2004
Listing Frankfurt Stock Exchange, General Standard: ECX
Location of business Berlin, Germany (Epigenomics AG)